Sandu Pharmaceuticals Ltd (524703) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524703 | NSE: | Pharmaceuticals & Drugs | Small Cap

Sandu Pharmaceutical Share Price

39.98 -0.22 -0.55%
as on 05-Dec'25 12:17

Sandu Pharmaceuticals Ltd (524703) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524703 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Sandu Pharmaceutical

Based on:

M-Cap below 100cr DeciZen not available

Sandu Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
23.83
Market Cap:
38.8 Cr.
52-wk low:
37
52-wk high:
62.8

Is Sandu Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Sandu Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sandu Pharmaceuticals Ltd is a below average quality company.

2. Is Sandu Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Sandu Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Sandu Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sandu Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sandu Pharmaceutical:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sandu Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7.7%5.3%7.1%7.6%5.8%7.9%9.4%6.9%6%6.9%-
Value Creation
Index
-0.5-0.6-0.5-0.5-0.6-0.4-0.3-0.5-0.6-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 41.142.84949.448.558.865.565.467.367.267
Sales YoY Gr.-4.3%14.5%0.8%-2%21.3%11.5%-0.2%3%-0.1%-
Adj EPS 0.8-0.70.7111.41.81.61.51.61.7
YoY Gr.--194.7%NA28.4%7.4%35.3%30.4%-12.2%-4.4%6%-
BVPS (₹) 26.425.126.227.428.229.630.740.63334.634.9
Adj Net
Profit
0.5-0.50.50.70.71.11.61.51.51.62
Cash Flow from Ops. -1.44.91.23.76.27.610.20.81-
Debt/CF from Ops. -82.27.61.70.200000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.6%6.8%0.9%-0.1%
Adj EPS 8.6%9.4%-3.9%6%
BVPS3.1%4.2%4.1%4.9%
Share Price 0% 3.9% -14.5% -30.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2.9-2.21.92.42.53.54.543.73.84.9
Op. Profit
Mgn %
74.354.23.23.74.43.83.44.14.2
Net Profit
Mgn %
1.3-1.21.11.41.51.92.42.32.22.32.5
Debt to
Equity
0.60.60.50.30.1000000
Working Cap
Days
23624018418117810910712513012776
Cash Conv.
Cycle
8710410110496504649587241

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 4.90%

Sales growth has been subdued in last 3 years 0.85%

Net Profit has been subdued in last 3 years -3.85%

Sales growth is not so good in last 4 quarters at -1.73%

Latest Financials - Sandu Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 1.7 1.6
TTM Sales (₹ Cr.) 66.8 67.2
BVPS (₹.) 34.9 34.6
Reserves (₹ Cr.) 24 24
P/BV 1.15 1.16
PE 23.83 25.02
From the Market
52 Week Low / High (₹) 37.00 / 62.80
All Time Low / High (₹) 2.50 / 86.00
Market Cap (₹ Cr.) 38.8
Equity (₹ Cr.) 9.7
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Sandu Pharmaceutical:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sandu Pharmaceutical - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Sandu Pharmaceutical

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales41.0842.8349.0249.4248.4558.7665.5065.3567.2867.19
Operating Expenses 38.2140.9746.5547.3346.9156.6062.6362.8664.9864.43
Manufacturing Costs1.380.911.422.482.883.504.103.713.823.95
Material Costs21.2925.6428.3925.3125.1134.5035.7431.1932.5732.10
Employee Cost 4.515.425.946.496.858.028.9111.1010.0710.92
Other Costs 11.039.0110.8013.0512.0710.5813.8716.8618.5217.46
Operating Profit 2.871.852.472.091.532.162.872.492.302.76
Operating Profit Margin (%) 7.0%4.3%5.0%4.2%3.2%3.7%4.4%3.8%3.4%4.1%
Other Income 0.150.470.120.570.380.190.080.330.420.17
Interest 1.641.491.231.010.430.120.110.080.060.10
Depreciation 0.690.870.600.640.550.560.530.520.580.67
Exceptional Items 00.090-0-000000
Profit Before Tax 0.680.050.761.020.921.682.322.222.072.16
Tax 0.140.500.190.350.200.590.730.700.610.61
Profit After Tax 0.54-0.440.560.670.721.091.591.521.461.55
PAT Margin (%) 1.3%-1.0%1.1%1.4%1.5%1.9%2.4%2.3%2.2%2.3%
Adjusted EPS (₹)0.8-0.60.80.91.01.41.81.61.51.6
Dividend Payout Ratio (%)0%0%0%0%0%36%42%48%53%50%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 18.6827.4128.0828.7929.2432.5936.0339.2440.6042.02
Share Capital 7.087.087.087.087.087.928.819.669.669.66
Reserves 11.6020.332121.7122.1624.6727.2229.5830.9332.36
Minority Interest0000000000
Debt10.8310.029.356.101.250.020000
Long Term Debt0.780.090.250.18000000
Short Term Debt10.059.939.115.931.250.020000
Trade Payables5.884.093.024.235.766.676.828.404.194.49
Others Liabilities 6.024.924.074.515.177.686.436.527.639.21
Total Liabilities 41.4146.4344.5343.6441.4146.9649.2854.1752.4255.72

Fixed Assets

Gross Block14.5025.1325.6725.7825.8926.0226.3827.5129.3530.29
Accumulated Depreciation6.697.648.108.739.299.8410.3710.8911.4712.14
Net Fixed Assets 7.8117.4917.5717.0416.6016.171616.6217.8818.15
CWIP 0000000.480.4200
Investments 0.730.991.121.130.820.249.119.6610.4311.22
Inventories12.0410.6811.4413.2614.3611.1411.2714.3312.2514.15
Trade Receivables7.156.356.694.804.685.353.994.794.874.76
Cash Equivalents 0.692.691.410.791.5411.664.172.291.202.65
Others Assets 12.988.246.296.623.402.414.266.075.794.79
Total Assets 41.4146.4344.5343.6441.4146.9649.2854.1752.4255.72

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -1.434.911.233.746.207.590.950.220.760.95
PBT 0.68-0.040.761.020.921.682.322.222.072.16
Adjustment 2.192.351.811.690.960.620.630.480.410.70
Changes in Working Capital -4.081.3-1.011.354.475.75-1.13-1.78-1.22-1.32
Tax Paid -0.221.30-0.32-0.31-0.14-0.46-0.88-0.70-0.50-0.58
Cash Flow From Investing Activity 0.05-0.59-0.62-0.10-0.37-5.58-5.470.53-1.31-0.18
Capex -0.15-0.61-0.63-0.11-0.11-0.13-0.84-1.07-1.43-0.94
Net Investments 0.05-0-0.010-0.28-5.64-4.641.44-0.040.64
Others 0.150.020.030.010.020.190.010.160.160.12
Cash Flow From Financing Activity -2.06-2.33-1.89-4.26-5.361.300.930.58-0.72-0.46
Net Proceeds from Shares 000002.641.381.3200
Net Proceeds from Borrowing -0.42-0.710.16-0.06-0.2400000
Interest Paid -1.64-1.49-1.23-1.01-0.43-0.11-0.11-0.08-0.06-0.10
Dividend Paid 000000-0.32-0.66-0.72-0.77
Others 0-0.12-0.82-3.18-4.68-1.23-0.0200.060.41
Net Cash Flow -3.441.99-1.28-0.620.483.31-3.591.33-1.270.31

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)2.92-2.443.093.533.665.036.294.64.114.74
ROCE (%)7.655.37.067.585.797.879.356.8966.91
Asset Turnover Ratio1.130.991.081.121.141.571.361.261.261.24
PAT to CFO Conversion(x)-2.65N/A2.25.588.616.960.60.140.520.61
Working Capital Days
Receivable Days53564842362626252626
Inventory Days969582911046762717272
Payable Days104714652736669897149

Sandu Pharmaceuticals Ltd Stock News

Sandu Pharmaceuticals Ltd FAQs

The current trading price of Sandu Pharmaceutical on 05-Dec-2025 12:17 is ₹39.98.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Sandu Pharmaceutical stood at ₹38.84.
The latest P/E ratio of Sandu Pharmaceutical as of 04-Dec-2025 is 23.83.
The latest P/B ratio of Sandu Pharmaceutical as of 04-Dec-2025 is 1.15.
The 52-week high of Sandu Pharmaceutical is ₹62.80 and the 52-week low is ₹37.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sandu Pharmaceutical is ₹66.76 ( Cr.) .

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

The company is part of Sandu Group of Companies, which was established in the year in 1899. It is also developing bio-technology and has got encouraging results for the residual, waste products generated after extraction of green herbs, roots, etc.

The company’s state-of-the-art manufacturing unit is located at Plot No. 25, 26, 29 and 30, Pilerne Industrial Estate, Marra, Bardez, Goa 403511.

Sandu Pharmaceuticals has received ISO 9001-2000 certification for its quality management.

It has also commenced operations of its ‘Sandu Ayurvedic Therapy Centre’, which its plans to establish centres across India via franchisee business model.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×